These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 15781808)

  • 1. Increased rate of major malformations in offspring exposed to valproate during pregnancy.
    Wyszynski DF; Nambisan M; Surve T; Alsdorf RM; Smith CR; Holmes LB;
    Neurology; 2005 Mar; 64(6):961-5. PubMed ID: 15781808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproic acid monotherapy in pregnancy and major congenital malformations.
    Jentink J; Loane MA; Dolk H; Barisic I; Garne E; Morris JK; de Jong-van den Berg LT;
    N Engl J Med; 2010 Jun; 362(23):2185-93. PubMed ID: 20558369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiepileptic drug use of women with epilepsy and congenital malformations in offspring.
    Artama M; Auvinen A; Raudaskoski T; Isojärvi I; Isojärvi J
    Neurology; 2005 Jun; 64(11):1874-8. PubMed ID: 15955936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The AED (antiepileptic drug) pregnancy registry: a 6-year experience.
    Holmes LB; Wyszynski DF; Lieberman E
    Arch Neurol; 2004 May; 61(5):673-8. PubMed ID: 15148143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations.
    Holmes LB; Mittendorf R; Shen A; Smith CR; Hernandez-Diaz S
    Arch Neurol; 2011 Oct; 68(10):1275-81. PubMed ID: 21670385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative safety of antiepileptic drugs during pregnancy.
    Hernández-Díaz S; Smith CR; Shen A; Mittendorf R; Hauser WA; Yerby M; Holmes LB; ;
    Neurology; 2012 May; 78(21):1692-9. PubMed ID: 22551726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Sabers A; Perucca E; Vajda F;
    Lancet Neurol; 2011 Jul; 10(7):609-17. PubMed ID: 21652013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproate teratogenicity and epilepsy syndrome.
    Bromfield EB; Dworetzky BA; Wyszynski DF; Smith CR; Baldwin EJ; Holmes LB
    Epilepsia; 2008 Dec; 49(12):2122-4. PubMed ID: 18557775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort.
    Omtzigt JG; Los FJ; Grobbee DE; Pijpers L; Jahoda MG; Brandenburg H; Stewart PA; Gaillard HL; Sachs ES; Wladimiroff JW
    Neurology; 1992 Apr; 42(4 Suppl 5):119-25. PubMed ID: 1574165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital structural anomalies in offspring of women with epilepsy--a population-based cohort study in Finland.
    Artama M; Ritvanen A; Gissler M; Isojärvi J; Auvinen A
    Int J Epidemiol; 2006 Apr; 35(2):280-7. PubMed ID: 16280367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal valproate dosage and foetal malformations.
    Vajda FJ; Eadie MJ
    Acta Neurol Scand; 2005 Sep; 112(3):137-43. PubMed ID: 16097954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy.
    Vajda FJ; O'brien TJ; Hitchcock A; Graham J; Cook M; Lander C; Eadie MJ
    J Clin Neurosci; 2004 Nov; 11(8):854-8. PubMed ID: 15519862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose dependence of fetal malformations associated with valproate.
    Vajda FJ; O'Brien TJ; Graham JE; Lander CM; Eadie MJ
    Neurology; 2013 Sep; 81(11):999-1003. PubMed ID: 23911758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of anticonvulsive drugs during pregnancy and the risk of malformations in the newborn: a meta-analysis].
    Gutiérrez-Alvarez AM
    Rev Neurol; 2003 Dec 1-15; 37(11):1022-8. PubMed ID: 14669141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the MTHFR genotype on the rate of malformations following exposure to antiepileptic drugs in utero.
    Kini U; Lee R; Jones A; Smith S; Ramsden S; Fryer A; Clayton-Smith J;
    Eur J Med Genet; 2007; 50(6):411-20. PubMed ID: 17951123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy, delivery, and outcome for the child in maternal epilepsy.
    Veiby G; Daltveit AK; Engelsen BA; Gilhus NE
    Epilepsia; 2009 Sep; 50(9):2130-9. PubMed ID: 19490036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy.
    Holmes LB; Baldwin EJ; Smith CR; Habecker E; Glassman L; Wong SL; Wyszynski DF
    Neurology; 2008 May; 70(22 Pt 2):2152-8. PubMed ID: 18448870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiepileptic drug regimens and major congenital abnormalities in the offspring.
    Samrén EB; van Duijn CM; Christiaens GC; Hofman A; Lindhout D
    Ann Neurol; 1999 Nov; 46(5):739-46. PubMed ID: 10553991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamotrigine and the risk of malformations in pregnancy.
    Cunnington M; Tennis P;
    Neurology; 2005 Mar; 64(6):955-60. PubMed ID: 15781807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epilepsy, antiepileptic drugs, and malformations in children of women with epilepsy: a French prospective cohort study.
    Dravet C; Julian C; Legras C; Magaudda A; Guerrini R; Genton P; Soulayrol S; Giraud N; Mesdjian E; Trentin G
    Neurology; 1992 Apr; 42(4 Suppl 5):75-82. PubMed ID: 1574181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.